Literature DB >> 21926845

The metabolic features of normal pancreas and pancreatic adenocarcinoma: preliminary result of in vivo proton magnetic resonance spectroscopy at 3.0 T.

Xiaohong Ma1, Xinming Zhao, Han Ouyang, Fei Sun, Hongmei Zhang, Chunwu Zhou, Hao Shen.   

Abstract

OBJECTIVE: The objective of the study was to analyze the metabolic features and distribution of normal pancreas and pancreatic adenocarcinoma while determining the biomarker of pancreatic cancerous process.
METHODS: Twenty-seven control and 29 pancreatic adenocarcinoma patients underwent breath-hold 3-T proton magnetic resonance spectroscopy. The ratios of lipid (lipid/InW), choline-containing compounds (CCCs/InW), and fatty acids (FAs/InW) to nonsaturated internal water (InW) of the normal pancreas head and body-tail region, with cancerous and noncancerous regions in pancreatic adenocarcinoma, were calculated.
RESULTS: In normal pancreas, there were no statistical difference in the ratios of FAs to InW and lipid to InW of different regions, but CCCs/InW of body-tail area was greater than that of head (7.28 × 10⁻⁴ vs 3.23 × 10⁻⁴). In pancreatic cancer, FAs/InW and lipid/InW between cancerous and noncancerous region were different (3.44 × 10⁻⁴ vs 16.3 × 10⁻⁴ and 7.78 × 10⁻⁴ vs 36.3 × 10⁻⁴, respectively). Choline-containing compounds/InW in cancerous region was smaller than that in noncancerous region of pancreatic head cancer (1.62 × 10⁻⁴ vs 5.69 × 10⁻⁴) but similar to such region in body-tail cancer. Lipid/InW dropped in noncancerous regions (from 0.67 to 0.36), whereas there were no differences in FAs/InW and CCCs/InW between normal pancreas regions and noncancerous regions in pancreatic cancer.
CONCLUSIONS: In normal pancreas, CCCs of body-tail region was greater than that of head. Whereas in pancreatic adenocarcinoma, CCCs, FAs, and lipid were all decreased in cancerous region, lipid in the noncancerous region was also decreased compared with normal pancreas. Lipid may be the potential sensitive biomarker for pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926845     DOI: 10.1097/RCT.0b013e318227a545

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  16 in total

Review 1.  The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.

Authors:  Douglas E Biancur; Alec C Kimmelman
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-24       Impact factor: 10.680

Review 2.  Magnetic resonance imaging of pancreatitis: an update.

Authors:  Sriluxayini Manikkavasakar; Mamdoh AlObaidy; Kiran K Busireddy; Miguel Ramalho; Viragi Nilmini; Madhavi Alagiyawanna; Richard C Semelka
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 3.  Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

Authors:  Roberto García-Figueiras; Sandra Baleato-González; Anwar R Padhani; Laura Oleaga; Joan C Vilanova; Antonio Luna; Juan Carlos Cobas Gómez
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 4.  Morphological and functional evaluation of chronic pancreatitis with magnetic resonance imaging.

Authors:  Tine Maria Hansen; Matias Nilsson; Mikkel Gram; Jens Brøndum Frøkjær
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

5.  Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism.

Authors:  Marie-France Penet; Tariq Shah; Santosh Bharti; Balaji Krishnamachary; Dmitri Artemov; Yelena Mironchik; Flonné Wildes; Anirban Maitra; Zaver M Bhujwalla
Journal:  Clin Cancer Res       Date:  2014-11-04       Impact factor: 12.531

6.  Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.

Authors:  Paul F Laeseke; Ru Chen; R Brooke Jeffrey; Teresa A Brentnall; Jürgen K Willmann
Journal:  Radiology       Date:  2015-12       Impact factor: 11.105

Review 7.  The complex landscape of pancreatic cancer metabolism.

Authors:  Cristovão Marques Sousa; Alec C Kimmelman
Journal:  Carcinogenesis       Date:  2014-04-17       Impact factor: 4.944

8.  HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.

Authors:  Alan S Wang; Alessia Lodi; Lee B Rivera; Jose L Izquierdo-Garcia; Matthew A Firpo; Sean J Mulvihill; Margaret A Tempero; Gabriele Bergers; Sabrina M Ronen
Journal:  NMR Biomed       Date:  2014-09-09       Impact factor: 4.044

Review 9.  Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up.

Authors:  Rushika M Perera; Nabeel Bardeesy
Journal:  Cancer Discov       Date:  2015-11-03       Impact factor: 39.397

10.  The Intricate Metabolism of Pancreatic Cancers.

Authors:  Felipe Camelo; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.